Out-Licensing
Sequella is seeking licensing partners for the products shown below. We welcome the opportunity to talk with potential partners about strategic fit and preferred partnering strategies. For additional information, please access the product links in the table below.
| PRODUCT CANDIDATE | R&D PHASE | THERAPEUTIC FOCUS |
|---|---|---|
| Phase III | TB | |
| Phase I | TB | |
| Proof-of-principle | Applications for multiple therapeutic areas | |
|
SQ609 |
Preclinical | TB, SARS, other anti-viral |
To discuss licensing opportunities, please contact:
Alan Klein
Executive Vice President, Corporate Development
Sequella Inc.
9610 Medical Center Drive, Suite 200
Rockville, MD 20850
Telephone: 301-762-7776